All lobbying filings

ACADIA PHARMACEUTICALS

Lobbying for ACADIA PHARMACEUTICALS

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $750,000.00 expenses · posted Oct 19, 2025

Official filing document

Bills named in this filing 7

HR 946
ORPHAN Cures Act
HR 1262
Mikaela Naylon Give Kids a Chance Act
HR 1414
Cameron’s Law
HR 1509
Accelerating Kids’ Access to Care Act of 2025
HR 3731
Small Biotech Innovation Act
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 3

Health Issues

Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).

Medicare/Medicaid

Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).

Taxation/Internal Revenue Code

Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.